Related Experiment Video
Updated: Jun 2, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Primary pulmonary mucinous cystadenocarcinoma: a case report
Andreas Efstathiou1, Christos Asteriou, Nikolaos Barbetakis
1Cardiothoracic Surgery Department, Theagenio Cancer Hospital, Al. Symeonidi 2, 54007 Thessaloniki, Greece.
Case Reports in Medicine
|May 5, 2011
Summary
Primary pulmonary mucinous cystadenocarcinoma (PMCAC) is an extremely rare cystic neoplasm. Long-term follow-up is crucial due to limited global experience with this rare lung cancer.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Primary pulmonary mucinous cystadenocarcinoma (PMCAC) is an exceptionally rare cystic neoplasm.
- Understanding the biological behavior and clinical presentation of PMCAC is limited.
Observation:
- A case report details a 56-year-old male with an inconclusive cystic lesion in the right lower lobe.
- Preoperative diagnostics, including fine needle aspiration cytology and bronchoscopy, were non-diagnostic.
Findings:
- The diagnosis of PMCAC was established intraoperatively following a right lower lobectomy and mediastinal lymph node dissection.
- The definitive diagnosis required surgical intervention due to inconclusive preoperative findings.
Implications:
- The biological behavior of primary PMCAC remains largely unknown.
- Extensive long-term patient follow-up is recommended due to the rarity and limited global experience with PMCAC.
- This case highlights the diagnostic challenges and the necessity of surgical resection for definitive PMCAC diagnosis.
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...